Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Saved in:
| Title: | Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. |
|---|---|
| Authors: | Folegatti PM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lopez FR; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bellamy D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kupke A; Institute of Virology, Philipps University of Marburg, Marburg, Germany; German Center for Infection Research, Thematic Translational Unit Emerging Infections, Marburg, Germany., Mair C; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Makinson R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sheridan J; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Rohde C; Institute of Virology, Philipps University of Marburg, Marburg, Germany; German Center for Infection Research, Thematic Translational Unit Emerging Infections, Marburg, Germany., Halwe S; Institute of Virology, Philipps University of Marburg, Marburg, Germany; German Center for Infection Research, Thematic Translational Unit Emerging Infections, Marburg, Germany., Jeong Y; International Vaccine Institute, Science Unit, Seoul, South Korea., Park YS; International Vaccine Institute, Science Unit, Seoul, South Korea., Kim JO; International Vaccine Institute, Science Unit, Seoul, South Korea., Song M; International Vaccine Institute, Science Unit, Seoul, South Korea., Boyd A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tran N; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Silman D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Datoo M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Marshall J; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Themistocleous Y; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lawrie A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Roberts R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Berrie E; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Becker S; Institute of Virology, Philipps University of Marburg, Marburg, Germany; German Center for Infection Research, Thematic Translational Unit Emerging Infections, Marburg, Germany., Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Hill A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ewer K; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: sarah.gilbert@ndm.ox.ac.uk. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Jul; Vol. 20 (7), pp. 816-826. Date of Electronic Publication: 2020 Apr 21. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
